• Home
  • Swasthya Healthcare Private Limited

Swasthya Healthcare Private Limited

About Swasthya Healthcare Private Limited

Swasthya Healthcare Pvt Ltd is an integrated pharmaceutical company based in Mumbai, India specialized in critical care products & having offices in Singapore, Ethiopia, Guatemala & Dubai. We are a Global Marketing partner for reputable companies, manufacturers in India, Indonesia and Korea. Our focus is to innovate marketing and establish health care products at reasonable costs without compromising quality. Having a strong presence in Central & Latin America, SE Asia & East African countries.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +91-9653373630
  • Website
  • 803/804 Devcorpora, Cadbury Junction,, khopat servi, Eastern Express Highway Thane, 400601, Mumbai, Maharashtra, India
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Swasthya Healthcare Private Limited (3)

  • Fingolimod Capsules 0.5 mg

    Product Fingolimod Capsules 0.5 mg

    Fingolimod, a sphingosine-1-phosphate (S1P) receptor modulator, is an effective therapy for Relapsing-Remitting Multiple Sclerosis (RRMS) that reduces relapses, slows disability progression, and enhances patient quality of life.

     Mechanism of Action (MOA): Modulates S1P receptors, which ...
  • Iohexol Injection USP 300mg-50ml

    Product Iohexol Injection USP 300mg-50ml

     Product Overview: Iohexol is widely used in computed tomography (CT) scans, angiography, and urography to improve image clarity, enabling precise diagnosis and treatment planning.

     Key Features:

    High-contrast enhancement for detailed imaging Excellent safety profile with l...
  • Leuprolide Depot Injection 22.5 mg

    Product Leuprolide Depot Injection 22.5 mg

    Mechanism of Action (MOA): Leuprolide acts as a GnRH agonist, initially stimulating but eventually suppressing LH & FSH secretion, leading to decreased testosterone in men and estrogen in women.
    Therapeutic UsProstate Cancer – Advanced and hormone-dependent cases
     Endometriosis – Sympto...

Recently Visited